A paperboard container for a pair of electric incandescent lamps which is in the form of a parellelepiped and includes as part thereof or secured thereto first and second pairs of lamp-engaging tab members which extend inwardly of the parrellelepiped to positively engage a respective one of the electric lamps at spaced locations thereon and cause the lamps to be in physical contact when positioned within the container. The container is formed from a single sheet of material through a series of f...

Disclosed is a random phase diffuser which is inserted between a transducer and an insonification subject in accoustical imaging. The diffuser is comprised of an array of lossless elements which cause sound emitted by the transducer to be passed through and emitted with a phase value of 0.degree. or 180.degree.. Additionally disclosed is the combination of a random phase diffuser with a wedge coupling feature for increasing insonification efficiency.

An apparatus for measuring the physical properties of a sample by optically monitoring the response of the sample to illumination by ultrashort optical pulses utilizes a common path optical interferometer of a Sagnac type that can measure physical properties at normal incidence. The interferometer is a two-arm Sagnac interferometer featuring three beam splitters. A sample is excited by a beam of ultrashort optical pulses, and variations in intensity and phase of another optical beam are detected...

The invention provides an apparatus for measuring the physical properties of a sample by optically monitoring the response of the sample to illumination by ultrashort optical pulses. The apparatus is a common path optical interferometer of a Sagnac type that can measure physical properties at normal incidence, i.e., a single-arm Sagnac interferometer featuring two beam splitters. Measurement is performed in such a manner that a sample is excited by a beam of ultrashort optical pulses, and variat...

The invention provides an apparatus for measuring the physical properties of a sample by optically monitoring the response of the sample to illumination by ultrashort optical pulses. The apparatus is a common path optical interferometer of a Sagnac type that can measure physical properties at normal incidence. The interferometer is a two-arm Sagnac interferometer featuring two beam splitters. Measurement is performed in such a manner that a sample is excited by a beam of ultrashort optical pulse...

This invention relates to high performance RIM (reaction injection molded) poly(urethane)urea elastomers, and to a process for their production. These elastomers comprise the reaction product of an allophanate-modified diphenylmethane diisocyanate prepolymer having an NCO group content of about 5 to about 30%, with an isocyanate-reactive component comprising a high molecular weight amine-terminated polyether polyol, an aromatic diamine chain extender, and, optionally, a chain extender or crossli...

Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: ##STR00001## including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: ##STR00002## and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, ...

Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: ##STR00001## including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: ##STR00002## and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, ...

Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: ##STR00001## including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: ##STR00002## and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, ...

Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: ##STR00001## including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: ##STR00002## and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, ...